{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:22:23Z","timestamp":1792167743438,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Charlotte and Tistou Kerstan Foundatio"},{"name":"ProRetina Foundation"},{"name":"Key Project of Yunnan Fundamental Research Projects"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Retinitis Pigmentosa (RP) is an inherited neurodegenerative disease which leads to loss of retinal photoreceptors and blindness. Histone deacetylases (HDAC) were previously found to be involved in photoreceptor cell death, and HDAC inhibitors have shown protective effects in animal models for autosomal recessive RP. However, whether HDAC inhibitors can protect photoreceptors in autosomal dominant RP (ADRP) remains unclear. Here, we utilized the recently generated human homologous\n                    <jats:italic>Rho<\/jats:italic>\n                    <jats:sup>I255d\/+<\/jats:sup>\n                    ADRP mouse model to investigate degenerative mechanisms and the therapeutic potential of HDAC inhibitors. To visualize photoreceptor HDAC activity, we applied an in situ HDAC activity assay on post-natal (P) day 20 wild type (WT) and\n                    <jats:italic>Rho<\/jats:italic>\n                    <jats:sup>I255d\/+<\/jats:sup>\n                    retina. Treatment with the HDAC class I\/II inhibitor Trichostatin A and the HDAC class III inhibitor nicotinamide (NAM) suggested that most HDAC activity detected in\n                    <jats:italic>Rho<\/jats:italic>\n                    <jats:sup>I255d\/+<\/jats:sup>\n                    photoreceptors was related to class I\/II isoforms. The therapeutic potential of different HDAC inhibitors, targeting different HDAC isoforms, was evaluated in vitro, on organotypic retinal explants cultured under completely controlled conditions. HDAC inhibitors tested included SAHA (Vorinostat), MPT0G211, ACY-957, and NAM. Readouts comprised the TUNEL assay, immunostaining for activated calpain-2 and caspase-3, cone arrestin-3, and bromodeoxyuridine (BrdU)-labeling. Among the compounds tested, MPT0G211, targeting predominantly cytoplasmic HDAC-6, exhibited the strongest protective effect on both rod and cone photoreceptors. Remarkably, high-dose ACY-957, inhibiting nuclear HDAC-1\/-2, induced both photoreceptor cell death and cell proliferation. High levels of NAM, blocking mitochondrial and nuclear HDACs, caused selective rod cell death, without affecting cones. All HDAC inhibitors tested had no or only minor effects on neurons of the inner retina. Our study highlights the complexity and ambiguity of HDAC activity during photoreceptor neurodegeneration and cautions against the use of unspecific inhibitors. At the same time, it showcases important differences between rod and cone photoreceptors and suggests especially HDAC-6 as a potential target for future therapy development.\n                  <\/jats:p>","DOI":"10.1038\/s41420-025-02908-9","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T05:36:00Z","timestamp":1765690560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential effects of HDAC inhibitors in the RhoI255d mouse model for autosomal dominant retinitis pigmentosa"],"prefix":"10.1038","volume":"12","author":[{"given":"Yu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Nanda Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3202-5993","authenticated-orcid":false,"given":"Kangwei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7355-5742","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Paquet-Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"2908_CR1","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795\u2013809.","journal-title":"Lancet"},{"key":"2908_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0002-9394(84)90636-6","volume":"97","author":"CH Bunker","year":"1984","unstructured":"Bunker CH, Berson EL, Bromley WC, Hayes RP, Roderick TH. Prevalence of retinitis pigmentosa in maine. Am J Ophthalmol. 1984;97:357\u201365.","journal-title":"Am J Ophthalmol"},{"key":"2908_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1399-0004.1987.tb02804.x","volume":"31","author":"J Grondahl","year":"1987","unstructured":"Grondahl J. Estimation of prognosis and prevalence of retinitis pigmentosa and Usher syndrome in Norway. Clin Genet. 1987;31:255\u201364.","journal-title":"Clin Genet"},{"key":"2908_CR4","first-page":"23","volume":"41","author":"K Novak-Lau\u0161","year":"2002","unstructured":"Novak-Lau\u0161 K, Kukulj S, Zori\u0107-Geber M, Bastai\u0107 O. Primary tapetoretinal dystrophies as the cause of blindness and impaired vision in the Republic of Croatia. Acta Clin Croatica. 2002;41:23\u20135.","journal-title":"Acta Clin Croatica"},{"key":"2908_CR5","unstructured":"RG FADSW. Nonsyndromic Retinitis Pigmentosa Overview. 2000. In: GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1417\/."},{"key":"2908_CR6","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.3390\/ijms20102542","volume":"20","author":"M Diakatou","year":"2019","unstructured":"Diakatou M, Manes G, Bocquet B, Meunier I, Kalatzis V. Genome editing as a treatment for the most prevalent causative genes of autosomal dominant retinitis pigmentosa. Int J Mol Sci. 2019;20:2542.","journal-title":"Int J Mol Sci"},{"key":"2908_CR7","doi-asserted-by":"crossref","unstructured":"Cao B, Zhu Y, G\u00fcnter A, Kilger E, Bolz S, Henes C, et al. Autosomal dominant Retinitis Pigmentosa caused by the rhodopsin isoleucine 255 deletion features rapid neuroretinal degeneration, decreased synaptic connectivity, and neuroinflammation. bioRxiv. 2024:2024.08.29.610258 [Preprint]. 2024. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2024.08.29.610258v1.","DOI":"10.1101\/2024.08.29.610258"},{"key":"2908_CR8","doi-asserted-by":"publisher","first-page":"e112142","DOI":"10.1371\/journal.pone.0112142","volume":"9","author":"B Arango-Gonzalez","year":"2014","unstructured":"Arango-Gonzalez B, Trifunovi\u0107 D, Sahaboglu A, Kranz K, Michalakis S, Farinelli P, et al. Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration. PLoS ONE. 2014;9:e112142.","journal-title":"PLoS ONE"},{"key":"2908_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.07.005","volume":"74","author":"M Power","year":"2020","unstructured":"Power M, Das S, Sch\u00fctze K, Marigo V, Ekstr\u00f6m P, Paquet-Durand F. Cellular mechanisms of hereditary photoreceptor degeneration - Focus on cGMP. Prog Retin Eye Res. 2020;74:100772.","journal-title":"Prog Retin Eye Res"},{"key":"2908_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fphar.2020.00537","volume":"11","author":"S Shukla","year":"2020","unstructured":"Shukla S, Tekwani BL. Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front Pharm. 2020;11:537.","journal-title":"Front Pharm"},{"key":"2908_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2183\/pjab.93.019","volume":"93","author":"M Yoshida","year":"2017","unstructured":"Yoshida M, Kudo N, Kosono S, Ito A. Chemical and structural biology of protein lysine deacetylases. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:297\u2013321.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2908_CR12","doi-asserted-by":"publisher","first-page":"17174","DOI":"10.1016\/S0021-9258(17)44885-X","volume":"265","author":"M Yoshida","year":"1990","unstructured":"Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem. 1990;265:17174\u20139.","journal-title":"J Biol Chem"},{"key":"2908_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/43710","volume":"401","author":"MS Finnin","year":"1999","unstructured":"Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature. 1999;401:188\u201393.","journal-title":"Nature"},{"key":"2908_CR14","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41418-020-00653-3","volume":"28","author":"M Samardzija","year":"2021","unstructured":"Samardzija M, Corna A, Gomez-Sintes R, Jarboui MA, Armento A, Roger JE, et al. HDAC inhibition ameliorates cone survival in retinitis pigmentosa mice. Cell Death Differ. 2021;28:1317\u201332.","journal-title":"Cell Death Differ"},{"key":"2908_CR15","first-page":"4462","volume":"25","author":"D Trifunovi\u0107","year":"2016","unstructured":"Trifunovi\u0107 D, Arango-Gonzalez B, Comitato A, Barth M, Del Amo EM, Kulkarni M, et al. HDAC inhibition in the cpfl1 mouse protects degenerating cone photoreceptors in vivo. Hum Mol Genet. 2016;25:4462\u201372.","journal-title":"Hum Mol Genet"},{"key":"2908_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-3-030-27378-1_63","volume":"1185","author":"M Samardzija","year":"2019","unstructured":"Samardzija M, Masarini K, Ueffing M, Trifunovi\u0107 D. HDAC inhibition prevents primary cone degeneration even after the onset of degeneration. Adv Exp Med Biol. 2019;1185:383\u20137.","journal-title":"Adv Exp Med Biol"},{"key":"2908_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/978-3-319-75402-4_45","volume":"1074","author":"D Trifunovi\u0107","year":"2018","unstructured":"Trifunovi\u0107 D, Petridou E, Comitato A, Marigo V, Ueffing M, Paquet-Durand F. Primary rod and cone degeneration is prevented by HDAC inhibition. Adv Exp Med Biol. 2018;1074:367\u201373.","journal-title":"Adv Exp Med Biol"},{"key":"2908_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2010.4","volume":"1","author":"J Sancho-Pelluz","year":"2010","unstructured":"Sancho-Pelluz J, Alavi M, Sahaboglu A, Kustermann S, Farinelli P, Azadi S, et al. Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse. Cell Death Dis. 2010;1:e24.","journal-title":"Cell Death Dis"},{"key":"2908_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/biom13040581","volume":"13","author":"Y Dong","year":"2023","unstructured":"Dong Y, Yan J, Yang M, Xu W, Hu Z, Paquet-Durand F, et al. Inherited retinal degeneration: towards the development of a combination therapy targeting histone deacetylase, poly (ADP-Ribose) polymerase, and calpain. Biomolecules. 2023;13:581.","journal-title":"Biomolecules"},{"key":"2908_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07901-9","volume":"16","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Peiroten L, Nanda Kumar P, et al. Protein kinase G inhibition preserves photoreceptor viability and function in a new mouse model for autosomal dominant retinitis pigmentosa. Cell Death Dis. 2025;16:575. https:\/\/doi.org\/10.1038\/s41419-025-07901-9.","journal-title":"Cell Death Dis"},{"key":"2908_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1073\/pnas.98.1.87","volume":"98","author":"R Furumai","year":"2001","unstructured":"Furumai R, Komatsu Y, Nishino N, Khochbin S, Yoshida M, Horinouchi S. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc Natl Acad Sci USA. 2001;98:87\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2908_CR22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1021\/acs.jmedchem.7b01404","volume":"61","author":"H-Y Lee","year":"2018","unstructured":"Lee H-Y, Nepali K, Huang F-I, Chang C-Y, Lai M-J, Li Y-H, et al. N-Hydroxycarbonylbenylamino)quinolines as selective histone deacetylase 6 inhibitors suppress growth of multiple myeloma in vitro and in vivo. J Med Chem. 2018;61:905\u201317.","journal-title":"J Med Chem"},{"key":"2908_CR23","doi-asserted-by":"publisher","first-page":"19895","DOI":"10.1021\/acsomega.9b02808","volume":"4","author":"ZF Kutil","year":"2019","unstructured":"Kutil ZF, Mikes\u030cova\u0301 J, Zessin M, Meleshin M, Nova\u0301kova\u0301 Z, Alquicer G, et al. Continuous activity assay for HDAC11 enabling reevaluation of HDAC inhibitors. ACS Omega. 2019;4:19895\u2013904.","journal-title":"ACS Omega"},{"key":"2908_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4155\/fmc.14.44","volume":"6","author":"J Hu","year":"2014","unstructured":"Hu J, Jing H, Lin H. Sirtuin inhibitors as anticancer agents. Future Med Chem. 2014;6:945\u201366.","journal-title":"Future Med Chem"},{"key":"2908_CR25","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1039\/D0RA09424B","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Zhao Y, Cao Z, Wang J, Liu T, Li Y, et al. Development of a mitochondrial sirtuin 4 FRET assay based on its activity for removing 3-hydroxy-3-methylglutaryl (HMG) modification. RSC Adv. 2021;11:2677\u201381.","journal-title":"RSC Adv"},{"key":"2908_CR26","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","volume":"63","author":"TCS Ho","year":"2020","unstructured":"Ho TCS, Chan AHY, Ganesan A. Thirty years of HDAC inhibitors: 2020 insight and hindsight. J Med Chem. 2020;63:12460\u201384.","journal-title":"J Med Chem"},{"key":"2908_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01391-y","volume":"22","author":"J Yan","year":"2024","unstructured":"Yan J, Wang L, Yang QL, Yang QX, He X, Dong Y, et al. T-type voltage-gated channels, Na(+)\/Ca(2+)-exchanger, and calpain-2 promote photoreceptor cell death in inherited retinal degeneration. Cell Commun Signal. 2024;22:92.","journal-title":"Cell Commun Signal"},{"key":"2908_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al. HDAC6 is a microtubule-associated deacetylase. Nature. 2002;417:455\u20138.","journal-title":"Nature"},{"key":"2908_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/science.1166226","volume":"323","author":"B Chen","year":"2009","unstructured":"Chen B, Cepko CL. HDAC4 regulates neuronal survival in normal and diseased retinas. Science. 2009;323:256\u20139.","journal-title":"Science"},{"key":"2908_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nature05853","volume":"447","author":"UB Pandey","year":"2007","unstructured":"Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature. 2007;447:859\u201363.","journal-title":"Nature"},{"key":"2908_CR31","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.bbamcr.2019.03.003","volume":"1866","author":"Y-L Hsieh","year":"2019","unstructured":"Hsieh Y-L, Tu H-J, Pan S-L, Liou J-P, Yang C-R. Anti-metastatic activity of MPT0G211, a novel HDAC6 inhibitor, in human breast cancer cells in vitro and in vivo. Biochim Biophys Acta Mol Cell Res. 2019;1866:992\u20131003.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2908_CR32","doi-asserted-by":"publisher","first-page":"e0153767","DOI":"10.1371\/journal.pone.0153767","volume":"11","author":"JR Shearstone","year":"2016","unstructured":"Shearstone JR, Golonzhka O, Chonkar A, Tamang D, van Duzer JH, Jones SS, et al. Chemical inhibition of histone deacetylases 1 and 2 induces fetal hemoglobin through activation of GATA2. PLoS ONE. 2016;11:e0153767.","journal-title":"PLoS ONE"},{"key":"2908_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1101\/gad.552310","volume":"24","author":"T Yamaguchi","year":"2010","unstructured":"Yamaguchi T, Cubizolles F, Zhang Y, Reichert N, Kohler H, Seiser C, et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 2010;24:455\u201369.","journal-title":"Genes Dev"},{"key":"2908_CR34","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1167\/iovs.07-0354","volume":"48","author":"KM Nishiguchi","year":"2007","unstructured":"Nishiguchi KM, Nakamura M, Kaneko H, Kachi S, Terasaki H. The role of VEGF and VEGFR2\/Flk1 in proliferation of retinal progenitor cells in murine retinal degeneration. Investig Ophthalmol Vis Sci. 2007;48:4315\u201320.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2908_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2184.2004.00296.x","volume":"37","author":"S Diermeier","year":"2004","unstructured":"Diermeier S, Schmidt-Bruecken E, Kubbies M, Kunz-Schughart LA, Brockhoff G. Exposure to continuous bromodeoxyuridine (BrdU) differentially affects cell cycle progression of human breast and bladder cancer cell lines. Cell Prolif. 2004;37:195\u2013206.","journal-title":"Cell Prolif"},{"key":"2908_CR36","first-page":"485","volume":"69","author":"RE Uzbekov","year":"2004","unstructured":"Uzbekov RE. Analysis of the cell cycle and a method employing synchronized cells for study of protein expression at various stages of the cell cycle. Biochemistry. 2004;69:485\u201396.","journal-title":"Biochemistry"},{"key":"2908_CR37","first-page":"153","volume":"24","author":"KL Bales","year":"2018","unstructured":"Bales KL, Ianov L, Kennedy AJ, Sweatt JD, Gross AK. Autosomal dominant retinitis pigmentosa rhodopsin mutant Q344X drives specific alterations in chromatin complex gene transcription. Mol Vis. 2018;24:153\u201364.","journal-title":"Mol Vis"},{"key":"2908_CR38","doi-asserted-by":"publisher","first-page":"e63205","DOI":"10.1371\/journal.pone.0063205","volume":"8","author":"S Nashine","year":"2013","unstructured":"Nashine S, Bhootada Y, Lewin AS, Gorbatyuk M. Ablation of C\/EBP homologous protein does not protect T17M RHO mice from retinal degeneration. PLoS ONE. 2013;8:e63205.","journal-title":"PLoS ONE"},{"key":"2908_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13045-018-0654-9","volume":"11","author":"T Li","year":"2018","unstructured":"Li T, Zhang C, Hassan S, Liu X, Song F, Chen K, et al. Histone deacetylase 6 in cancer. J Hematol Oncol. 2018;11:111.","journal-title":"J Hematol Oncol"},{"key":"2908_CR40","doi-asserted-by":"publisher","first-page":"14946","DOI":"10.1021\/acs.jmedchem.4c00477","volume":"67","author":"G Carullo","year":"2024","unstructured":"Carullo G, Orsini N, Piano I, Pozzetti L, Papa A, Fontana A, et al. Targeting relevant HDACs to support the survival of cone photoreceptors in inherited retinal diseases: identification of a potent pharmacological tool with in vitro and in vivo efficacy. J Med Chem. 2024;67:14946\u201373.","journal-title":"J Med Chem"},{"key":"2908_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116174","volume":"228","author":"L Yang","year":"2024","unstructured":"Yang L, Guttman L, Dawson VL, Dawson TM. Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke. Biochem Pharm. 2024;228:116174.","journal-title":"Biochem Pharm"},{"key":"2908_CR42","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.cub.2008.10.029","volume":"18","author":"H Okawa","year":"2008","unstructured":"Okawa H, Sampath AP, Laughlin SB, Fain GL. ATP consumption by mammalian rod photoreceptors in darkness and in light. Curr Biol. 2008;18:1917\u201321.","journal-title":"Curr Biol"},{"key":"2908_CR43","doi-asserted-by":"publisher","first-page":"19599","DOI":"10.1073\/pnas.2001776117","volume":"117","author":"NT Ingram","year":"2020","unstructured":"Ingram NT, Fain GL, Sampath AP. Elevated energy requirement of cone photoreceptors. Proc Natl Acad Sci USA. 2020;117:19599\u2013603.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2908_CR44","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/MCB.00869-06","volume":"27","author":"F Escaffit","year":"2007","unstructured":"Escaffit F, Vaute O, Chevillard-Briet M, Segui B, Takami Y, Nakayama T, et al. Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important for apoptosis progression. Mol Cell Biol. 2007;27:554\u201367.","journal-title":"Mol Cell Biol"},{"key":"2908_CR45","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1091\/mbc.e03-08-0624","volume":"15","author":"G Paroni","year":"2004","unstructured":"Paroni G, Mizzau M, Henderson C, Del Sal G, Schneider C, Brancolini C. Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol Biol Cell. 2004;15:2804\u201318.","journal-title":"Mol Biol Cell"},{"key":"2908_CR46","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1523\/JNEUROSCI.23-13-05723.2003","volume":"23","author":"F Doonan","year":"2003","unstructured":"Doonan F, Donovan M, Cotter TG. Caspase-independent photoreceptor apoptosis in mouse models of retinal degeneration. J Neurosci. 2003;23:5723\u201331.","journal-title":"J Neurosci"},{"key":"2908_CR47","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.3390\/ijms23073892","volume":"23","author":"S Belhadj","year":"2022","unstructured":"Belhadj S, Hermann NS, Zhu Y, Christensen G, Strasser T, Paquet-Durand F. Visualizing cell death in live retina: using calpain activity detection as a biomarker for retinal degeneration. Int J Mol Sci. 2022;23:3892.","journal-title":"Int J Mol Sci"},{"key":"2908_CR48","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2174\/1570159X17666190228112451","volume":"17","author":"M Baudry","year":"2019","unstructured":"Baudry M. Calpain-1 and Calpain-2 in the brain: Dr. Jekill and Mr Hyde?. Curr Neuropharmacol. 2019;17:823\u20139.","journal-title":"Curr Neuropharmacol"},{"key":"2908_CR49","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/cne.24807","volume":"528","author":"MJ Power","year":"2020","unstructured":"Power MJ, Rogerson LE, Schubert T, Berens P, Euler T, Paquet-Durand F. Systematic spatiotemporal mapping reveals divergent cell death pathways in three mouse models of hereditary retinal degeneration. J Comp Neurol. 2020;528:1113\u201339.","journal-title":"J Comp Neurol"},{"key":"2908_CR50","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.molcel.2005.02.022","volume":"17","author":"JL Avalos","year":"2005","unstructured":"Avalos JL, Bever KM, Wolberger C. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD+ cosubstrate specificity of a Sir2 enzyme. Mol Cell. 2005;17:855\u201368.","journal-title":"Mol Cell"},{"key":"2908_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.lfs.2017.06.003","volume":"181","author":"Y Feng","year":"2017","unstructured":"Feng Y, Wang Y, Jiang C, Fang Z, Zhang Z, Lin X, et al. Nicotinamide induces mitochondrial-mediated apoptosis through oxidative stress in human cervical cancer HeLa cells. Life Sci. 2017;181:62\u20139.","journal-title":"Life Sci"},{"key":"2908_CR52","doi-asserted-by":"publisher","first-page":"RP91141","DOI":"10.7554\/eLife.91141","volume":"12","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zizmare L, Calbiague V, Wang L, Yu S, Herberg FW, et al. Retinal metabolism: evidence for uncoupling of glycolysis and oxidative phosphorylation via Cori-, Cahill-, and mini-Krebs-cycle. ELife. 2024;12:RP91141.","journal-title":"ELife"},{"key":"2908_CR53","doi-asserted-by":"publisher","first-page":"12170","DOI":"10.3390\/ijms232012170","volume":"23","author":"Y Chen","year":"2022","unstructured":"Chen Y, Dong Y, Yan J, Wang L, Yu S, Jiao K, et al. Single-cell transcriptomic profiling in inherited retinal degeneration reveals distinct metabolic pathways in rod and cone photoreceptors. Int J Mol Sci. 2022;23:12170.","journal-title":"Int J Mol Sci"},{"key":"2908_CR54","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tibs.2010.07.003","volume":"35","author":"E Verdin","year":"2010","unstructured":"Verdin E, Hirschey MD, Finley LW, Haigis MC. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci. 2010;35:669\u201375.","journal-title":"Trends Biochem Sci"},{"key":"2908_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fphar.2012.00022","volume":"3","author":"B Martinez-Pastor","year":"2012","unstructured":"Martinez-Pastor B, Mostoslavsky R. Sirtuins, metabolism, and cancer. Front Pharm. 2012;3:22.","journal-title":"Front Pharm"},{"key":"2908_CR56","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1172\/JCI86905","volume":"126","author":"L Zhang","year":"2016","unstructured":"Zhang L, Du J, Justus S, Hsu CW, Bonet-Ponce L, Wu WH, et al. Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration. J Clin Invest. 2016;126:4659\u201373.","journal-title":"J Clin Invest"},{"key":"2908_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.cell.2015.03.023","volume":"161","author":"N A\u00eft-Ali","year":"2015","unstructured":"A\u00eft-Ali N, Fridlich R, Millet-Puel G, Cl\u00e9rin E, Delalande F, Jaillard C, et al. Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis. Cell. 2015;161:817\u201332.","journal-title":"Cell"},{"key":"2908_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1615\/CritRevEukaryotGeneExpr.2013006875","volume":"24","author":"J Morales","year":"2014","unstructured":"Morales J, Li L, Fattah FJ, Dong Y, Bey EA, Patel M, et al. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. Crit Rev Eukaryot Gene Expr. 2014;24:15\u201328.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"2908_CR59","unstructured":"Zhu Y, A Fallatah AH, Jiao K, Seeliger MW, Paquet-Durand F. PARP activity is essential for retinal photoreceptor survival in the human homologous RhoI255del mouse model for autosomal dominant retinitis pigmentosa. bioRxiv. 2025:2025.08.21.671267 [Preprint]. 2025. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2025.08.21.671267v1."},{"key":"2908_CR60","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1016\/j.celrep.2016.10.074","volume":"17","author":"J-W Kim","year":"2016","unstructured":"Kim J-W, Yang H-J, Brooks MJ, Zelinger L, Karak\u00fclah G, Gotoh N, et al. NRL-regulated transcriptome dynamics of developing rod photoreceptors. Cell Rep. 2016;17:2460\u201373.","journal-title":"Cell Rep"},{"key":"2908_CR61","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.1128\/MCB.00494-07","volume":"27","author":"S Senese","year":"2007","unstructured":"Senese S, Zaragoza K, Minardi S, Muradore I, Ronzoni S, Passafaro A, et al. Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol. 2007;27:4784\u201395.","journal-title":"Mol Cell Biol"},{"key":"2908_CR62","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s12272-015-0571-1","volume":"38","author":"P Chun","year":"2015","unstructured":"Chun P. Histone deacetylase inhibitors in hematological malignancies and solid tumors. Arch Pharm Res. 2015;38:933\u201349.","journal-title":"Arch Pharm Res"},{"key":"2908_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-152","volume":"13","author":"E Juengel","year":"2014","unstructured":"Juengel E, Nowaz S, Makarevi J, Natsheh I, Werner I, Nelson K, et al. HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A. Mol Cancer. 2014;13:152.","journal-title":"Mol Cancer"},{"key":"2908_CR64","doi-asserted-by":"publisher","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, Seto E. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med. 2016;6:a026831.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2908_CR65","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/dvdy.20427","volume":"233","author":"JA Stadler","year":"2005","unstructured":"Stadler JA, Shkumatava A, Norton WH, Rau MJ, Geisler R, Fischer S, et al. Histone deacetylase 1 is required for cell cycle exit and differentiation in the zebrafish retina. Dev Dyn. 2005;233:883\u20139.","journal-title":"Dev Dyn"},{"key":"2908_CR66","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","volume":"76","author":"A Krumm","year":"2016","unstructured":"Krumm A, Barckhausen C, K\u00fcc\u00fck P, Tomaszowski KH, Loquai C, Fahrer J, et al. Enhanced histone deacetylase activity in malignant melanoma provokes RAD51 and FANCD2-triggered drug resistance. Cancer Res. 2016;76:3067\u201377.","journal-title":"Cancer Res"},{"key":"2908_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09743-8","volume":"7","author":"SPB Sardar Pasha","year":"2017","unstructured":"Sardar Pasha SPB, M\u00fcnch R, Sch\u00e4fer P, Oertel P, Sykes AM, Zhu Y, et al. Retinal cell death dependent reactive proliferative gliosis in the mouse retina. Sci Rep. 2017;7:9517.","journal-title":"Sci Rep"},{"key":"2908_CR68","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/glia.23130","volume":"65","author":"P Sch\u00e4fer","year":"2017","unstructured":"Sch\u00e4fer P, Karl MO. Prospective purification and characterization of M\u00fcller glia in the mouse retina regeneration assay. Glia. 2017;65:828\u201347.","journal-title":"Glia"},{"key":"2908_CR69","doi-asserted-by":"publisher","unstructured":"Belhadj S, Tolone A, Christensen G, Das S, Chen Y, Paquet-Durand F. Long-term, serum-free cultivation of organotypic mouse retina explants with intact retinal pigment epithelium. J Vis Exp. 2020;e61868. https:\/\/doi.org\/10.3791\/61868.","DOI":"10.3791\/61868"},{"key":"2908_CR70","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.119.3.493","volume":"119","author":"Y Gavrieli","year":"1992","unstructured":"Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493\u2013501.","journal-title":"J Cell Biol"},{"key":"2908_CR71","doi-asserted-by":"crossref","unstructured":"Sahaboglu A, Barth M, Secer E, Amo EMd, Urtti A, Arsenijevic Y, et al. Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration. Sci Rep. 2016;6:39537.","DOI":"10.1038\/srep39537"},{"key":"2908_CR72","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s00467-006-0072-z","volume":"21","author":"EM Slominska","year":"2006","unstructured":"Slominska EM, Kowalik K, Smolenski RT, Szolkiewicz M, Rutkowski P, Rutkowski B, et al. Accumulation of poly (ADP-ribose) polymerase inhibitors in children with chronic renal failure. Pediatr Nephrol. 2006;21:800\u20136.","journal-title":"Pediatr Nephrol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02908-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:02:40Z","timestamp":1769536960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02908-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2908"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02908-9","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures were performed using the ARVO statement for using animals in ophthalmic and visual research. Animal protocols compliant with \u00a74 of the German law of animal protection were reviewed and approved by the T\u00fcbingen University committee on animal protection (Einrichtung f\u00fcr Tierschutz, Tier\u00e4rztlicher Dienst und Labortierkunde, Registration No. AK02\/19M, AK01\/22M).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"57"}}